Mabylon (private company)
See something wrong or missing? Let us know
Offices:Zurich
Industry:BiotechHealth servicesPharma
Business model:B2B
Mabylon is a Swiss biotech startup developing a clinical-stage lead candidate MY006 which uses human-derived antibodies to treat allergies, neurodegenerative diseases, and inflammation.
values in USD
Investments 37.21M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Mabylon
Name | Criteria | |
---|---|---|
![]() |
AbolerIS Pharma
55%
|
|
![]() |
Acesion Pharma
55%
|
|
![]() |
AFYX Therapeutics
55%
|
|
![]() |
Cinclus Pharma
55%
|
|
![]() |
Citryll
55%
|
|
![]() |
DelSiTech
55%
|
|
![]() |
iCellate
55%
|
|
![]() |
ITBMed
55%
|
|
![]() |
Nanoform Finland
55%
|
|
![]() |
NMD Pharma
55%
|
|